Computed Tomography-Based Radiomics Using Tumor and Vessel Features to Assess Resectability in Cancer of the Pancreatic Head
Authors:
- Geke LitjensGLGeke Litjens
- Geke LitjensGLGeke Litjens
- Joris P. E. A. BroekmansJBJoris P. E. A. Broekmans
- Joris P. E. A. BroekmansJBJoris P. E. A. Broekmans
- Tim BoersTim Boers
- Tim BoersTim Boers
- Marco CaballoMarco Caballo
- Marco CaballoMarco Caballo
- Maud H. F. van Den HurkMHMaud H. F. van Den Hurk
- Maud H. F. van Den HurkMHMaud H. F. van Den Hurk
- Dilek OzdemirDODilek Ozdemir
- Dilek OzdemirDODilek Ozdemir
Open Access
- 13 October 2023
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 13 (20) , 3198
Abstract
The preoperative prediction of resectability pancreatic ductal adenocarcinoma (PDAC) is challenging. This retrospective single-center study examined tumor and vessel radiomics to predict the resectability of PDAC in chemo-naïve patients. The tumor and adjacent arteries and veins were segmented in the portal-venous phase of contrast-enhanced CT scans, and radiomic features were extracted. Features were selected via stability and collinearity testing, and least absolute shrinkage and selection operator application (LASSO). Three models, using tumor features, vessel features, and a combination of both, were trained with the training set (N = 86) to predict resectability. The results were validated with the test set (N = 15) and compared to the multidisciplinary team’s (MDT) performance. The vessel-features-only model performed best, with an AUC of 0.92 and sensitivity and specificity of 97% and 73%, respectively. Test set validation showed a sensitivity and specificity of 100% and 88%, respectively. The combined model was as good as the vessel model (AUC = 0.91), whereas the tumor model showed poor performance (AUC = 0.76). The MDT’s prediction reached a sensitivity and specificity of 97% and 84% for the training set and 88% and 100% for the test set, respectively. Our clinician-independent vessel-based radiomics model can aid in predicting resectability and shows performance comparable to that of the MDT. With these encouraging results, improved, automated, and generalizable models can be developed that reduce workload and can be applied in non-expert hospitals.Keywords
This publication has 46 references indexed in Scilit:
- Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trialTrials, 2016
- Radiomics: Images Are More than Pictures, They Are DataRadiology, 2016
- Impact of the Time Interval Between MDCT Imaging and Surgery on the Accuracy of Identifying Metastatic Disease in Patients With Pancreatic CancerAmerican Journal of Roentgenology, 2015
- Diagnostic accuracy of EUS and CT of vascular invasion in pancreatic cancer: a systematic reviewJournal of Cancer Research and Clinical Oncology, 2014
- Resection Margins in Pancreatic CancerSurgical Clinics of North America, 2013
- Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicatorsCancer, 2012
- Downstaging Chemotherapy and Alteration in the Classic Computed Tomography/Magnetic Resonance Imaging Signs of Vascular Involvement in Patients With Pancreaticobiliary Malignant TumorsArchives of Surgery, 2011
- User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliabilityNeuroImage, 2006
- Forming inferences about some intraclass correlation coefficients.Psychological Methods, 1996
- A method of comparing the areas under receiver operating characteristic curves derived from the same cases.Radiology, 1983